ResMed

Yahoo Finance • 8 days ago

ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly Beat

ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections, shrugging off weight-loss drug worries. Continue reading View comments... Full story

Yahoo Finance • 30 days ago

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

ResMed Inc. SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the... Full story

Yahoo Finance • last month

Is ResMed Inc.'s (NYSE:RMD) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

ResMed's (NYSE:RMD) stock is up by a considerable 26% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be paying attention t... Full story

Yahoo Finance • 2 months ago

ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange

ResMed Inc. Learn more about ResMed’s 2030 strategy to accelerate growth Join in person or via virtual webcast SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an investor day on Monday, September 30,... Full story

Yahoo Finance • 2 months ago

ResMed Insiders Sold US$16m Of Shares Suggesting Hesitancy

The fact that multiple ResMed Inc. (NYSE:RMD) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insiders are buying is usually more helpful when evaluat... Full story

Yahoo Finance • 2 months ago

ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

ResMed Inc. SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at... Full story

Yahoo Finance • 2 months ago

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%

Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Financials, Technology and Telecoms sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average rose 0.02% to hit a new all time hig... Full story

Yahoo Finance • 6 months ago

MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access

MatrixCare The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes. BLOOMINGTON, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- MatrixCar... Full story

Yahoo Finance • 6 months ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Sector Update: Health Care Stocks Edge Higher Late Afternoon... Full story

Yahoo Finance • 6 months ago

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

ResMed Inc. Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://in... Full story

Yahoo Finance • 9 months ago

ResMed CEO: Weight-Loss Drugs Aren’t Cutting Demand for Sleep Apnea Treatment

As excitement built last year over weight-loss drugs from Novo Nordisk and Eli Lilly investors abandoned companies that treat disorders inflamed by obesity. Shares of ResMed sank 40% from July to October, on fears that fewer people would s... Full story

Yahoo Finance • 9 months ago

Q2 2024 Resmed Inc Earnings Call

Participants Amy Wakeham; Chief IR Officer; ResMed Inc. Brett A. Sandercock; CFO; ResMed Inc. Michael J. Farrell; CEO & Chairman; ResMed Inc. Anthony Charles Petrone; MD & Senior Medical Devices, Diagnostics and Therapeutics Equity Res... Full story

Yahoo Finance • 10 months ago

ResMed says its masks to remain on market despite FDA classification

Jan 16 (Reuters) - ResMed said its respiratory masks containing magnets will remain on the market even though the U.S. Food and Drug Administration classified a recall of the product as most serious as their use could cause major injuries... Full story

Yahoo Finance • 10 months ago

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

ResMed Inc. SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monda... Full story

Yahoo Finance • 11 months ago

ResMed Secures Significant Victory in Patent Fight Against New York University

ResMed Inc. SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York Univer... Full story

Yahoo Finance • 12 months ago

ResMed Inc's Dividend Analysis

Assessing the Sustainability and Growth of ResMed Inc's Dividend ResMed Inc(NYSE:RMD) recently announced a dividend of $0.48 per share, payable on 2023-12-14, with the ex-dividend date set for 2023-11-08. As investors look forward to this... Full story

Yahoo Finance • 12 months ago

2 Monster Stocks to Buy Without Any Hesitation

First, consumer health juggernaut Kenvue (NYSE: KVUE) produces and markets seven No. 1 global brands. Meanwhile, ResMed (NYSE: RMD), a leader in continuous positive airway pressure (CPAP) machines, has delivered enormous total returns of o... Full story

Yahoo Finance • last year

ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023

ResMed Inc. SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2024 on Thursday, October 26, 2023, after the... Full story

Yahoo Finance • last year

ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023

ResMed Inc. SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the... Full story

Yahoo Finance • last year

ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 74% of the company

Key Insights Given the large stake in the stock by institutions, ResMed's stock price might be vulnerable to their trading decisions The top 18 shareholders own 50% of the company Recent sales by insiders A look at the shareholders of Re... Full story